retatrutide fat loss study nonalcoholic fatty liver disease trial Retatrutide in Canada: Clinical Results, Cost Expectations, and Patient Experience Nonalcoholic fatty liver disease: Current – Comment “Curious” for the deep

Adults using a GLP-1 had an increase in GFR from 50.48 mL/min/1.73 m 2 at baseline to 53.44 mL/min/1.73 m 2 at 6 months, whereas the control group had a decrease from 43.4 mL/min/1.73 m 2 at baseline to 40.84 mL/min/1.73 m 2 at 6 months ( P = .03)

They help regulate appetite and insulin secretion, leading to decreased hunger and improved feelings of fullness

This doesnt happen to everyone who takes Ozempic or other GLP-1 medications

Wernicke encephalopathy, a life-threatening complication of thiamine deficiency characterized by ophthalmoparesis, ataxia, confusion, and nystagmus 60,61 , has been reported in patients using semaglutide 62